Orgentec Diagnostika, a portfolio company of Water Street Healthcare Partners, has agreed to acquire Corgenix Medical Corp. for approximately $16 million. According to terms of the agreement, Corgenix shareholders will receive $.27 in cash for each share of common stock they own. The deal is expected to close in the fourth quarter of this year. Inverness Advisors, a division of KEMA Partners, provided financial advice to Corgenix on the transaction. Headquartered in Broomfield, Colorado, Corgenix is a maker of diagnostic test kits.